scispace - formally typeset
P

Pamela C. Ronald

Researcher at University of California, Davis

Publications -  326
Citations -  31672

Pamela C. Ronald is an academic researcher from University of California, Davis. The author has contributed to research in topics: Xanthomonas oryzae & Gene. The author has an hindex of 83, co-authored 315 publications receiving 27600 citations. Previous affiliations of Pamela C. Ronald include Energy Institute & International Rice Research Institute.

Papers
More filters
Patent

Procedures et materiaux destines a conferer a des plantes la resistance a des maladies

TL;DR: Acides nucleiques codant des polypeptides qui conferent la resistance a Xanthomonas spp.
Patent

Inhibition of a Xylosyltransferase to Improve Saccharification Efficiency

TL;DR: In this article, the authors provide compositions and methods for inhibiting the expression of the gene XAX1 in grass plants, which have use in biofuel production by increasing the amount of soluble sugar that can be extracted from the plant.
Journal ArticleDOI

Field performance of switchgrass plants engineered for reduced recalcitrance

TL;DR: In this paper , transgenic switchgrass plants overexpressing either OsAT10 or QsuB were tested in the field in Davis, California, USA for three growing seasons, and no significant differences in the content of lignin and cell wall-bound p-coumaric acid or ferulic acid were detected in transgenic OsAT 10 lines compared with the untransformed Alamo control variety.
Journal ArticleDOI

An open source plant kinase chemogenomics set

TL;DR: The binding of human and rice kinases to the same compound suggests that human kinase inhibitor sets will be useful for dissecting the function of plant kinases.
Journal ArticleDOI

Silencing of Dicer-like protein 2a restores the resistance phenotype in the rice mutant, sxi4 (suppressor of Xa21-mediated immunity 4).

TL;DR: A CRISPR knockout of a short interfering RNA (TE-siRNA815) in the intron of WRKY45-1 restores the resistance phenotype in sxi4, suggesting a model where DCL2a accumulation negatively regulates XA21-mediated immunity by altering the processing of TE-si RNA815.